XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 100 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $332,370 | +87.0% | 147,720 | +83.7% | 0.00% | – |
| Q1 2024 | $177,728 | -6.0% | 80,420 | 0.0% | 0.00% | – |
| Q4 2023 | $188,987 | +26.3% | 80,420 | 0.0% | 0.00% | – |
| Q3 2023 | $149,581 | -19.0% | 80,420 | +14.2% | 0.00% | – |
| Q2 2023 | $184,579 | +187.4% | 70,450 | +78.8% | 0.00% | – |
| Q1 2023 | $64,222 | +22.6% | 39,400 | 0.0% | 0.00% | – |
| Q4 2022 | $52,402 | +37.9% | 39,400 | +63.5% | 0.00% | – |
| Q3 2022 | $38,000 | +81.0% | 24,100 | +74.6% | 0.00% | – |
| Q2 2022 | $21,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |